Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
SYRA$0.88-0.01(-0.68%)Syra Health To Announce Third Quarter 2026 Financial Results Syra Health Corp. (OTCQB: SYRA), ("Syra Health" or the "Company"), an integrated healthcare solutions company powering better health outcomes through ...[9:06:00 AM ET]DFIN$54.21-1.31(-2.36%)DFIN Announces Venue® MCP Connector, Bringing Secure AI Access to High-Stakes Deal Workflows Donnelley Financial Solutions (NYSE: DFIN), a leading global provider of financial regulatory and compliance solutions and the top SEC filing agent,...[9:05:00 AM ET]AWK$142.08-0.67(-0.47%)American Water Contributes Expertise at California Water Association 2026 Summit American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., will join important conversations and contribute...[9:03:00 AM ET]TFC$48.91+0.47(+0.97%)Truist names Alex Bartlett regional president for Greater Washington and Maryland Truist Financial Corporation (NYSE: TFC) today announced Alex Bartlett has been named regional president for Greater Washington and Maryland. A...[9:03:00 AM ET]MKTW$19.58+0.75(+3.98%)MarketWise, Inc. Declares Quarterly Dividend on Class A Common Stock of $0.45 Per Share[9:00:14 AM ET]UFPI$80.93-0.30(-0.37%)UFP Packaging Expands Gulf Coast Pallet Network with Acquisition of Apache Products UFP Packaging, a division of UFP Industries (Nasdaq: UFPI), announced this week the acquisition of Apache Products, Inc., a pallet producer based in...[9:00:00 AM ET]THFF$77.70+1.24(+1.62%)First Financial Corporation Reports Third Quarter Results[9:00:00 AM ET]FTNT$181.84-1.49(-0.81%)Fortinet Expands Unified SASE to Simplify Microbranch Security[9:00:00 AM ET]VELO$6.61+0.12(+1.85%)Velo3D to Announce Third Quarter 2026 Results on November 10, 2026 Velo3D, Inc. (Nasdaq: VELO), a leading metal additive manufacturing technology company, today announced that it will release its third quarter 2026...[9:00:00 AM ET]CPB$20.53-0.10(-0.48%)Campbell's® Marks Five Years of Sides Season™ with Its Annual State of the Sides Report Campbell's officially kicked off Sides Season™ with the release of its 2026 State of the Sides Report. Now in its fifth year, the report offers a...[9:00:00 AM ET]COCO$55.80-0.73(-1.30%)Vita Coco® Introduces Vita Coco Kids, Designed for the Next Generation of Coconut Water Drinkers and Available Exclusively at Select Walmart Locations[9:00:00 AM ET]TENB$47.55-0.66(-1.37%)Tenable Selected by Atos to Power Continuous Threat Exposure Management Program[9:00:00 AM ET]PLUR$1.23+0.11(+9.82%)Pluri to Host Investor Conference Calls to Discuss Updates and Strategic Developments[9:00:00 AM ET]

ABSI · NASDAQ

Absci Corporation

$9.58 +0.12 (+1.32%)

Company overview

Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using an integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.

Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Market cap
$1.6B
Employees
156
Headquarters
Vancouver, WA
Website
absci.com
CEO
Sean McClain
Listed
July 22, 2021
P/E
-11.54
Dividend yield
0.00%

Company financials

Revenue
$1.8M
Gross profit
-$24.2M
Operating income
-$129M
EBITDA
-$116M
Net income
-$118M
EPS
-$0.83
Total assets
$196M
Total debt
$4.4M
Gross margin
-1,316.88%
Net margin
-6,450.76%
Earnings yield
-8.66%

Revenue segmentation

By product

No annual segmentation.

By region

No geographic segmentation.

Price chart

3.295.577.8410.1212.39
ABSI 1D NASDAQ O9.19H9.76L9.09C9.46+0.28 (+3.00%)Vol1.21M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
ABSIAbsci Corporation Press release Absci to Participate in Upcoming Investor Conferences GlobeNewswire
ABSIAbsci Corporation Press release AI Can Design Antibodies Faster Than Anyone Can Check Them for Immune Risk. That Gap Is Starting to Close. GlobeNewswire
ABSIAbsci Corporation Press release AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test GlobeNewswire
ABSIAbsci Corporation Press release Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026 GlobeNewsWire
ABSIAbsci Corporation Stock news Critical Contrast: Absci (NASDAQ:ABSI) and Black Diamond Therapeutics (NASDAQ:BDTX) Defense World
ABSIAbsci Corporation Press release Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis GlobeNewsWire
ABSIAbsci Corporation Stock news Contrasting Absci (NASDAQ:ABSI) & Valneva (NASDAQ:VALN) Defense World
ABSIAbsci Corporation Stock news Absci Corporation (ABSI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript Seeking Alpha
ABSIAbsci Corporation Stock news Absci: Positive Ph1 Data ABS-201 AGA And Several Catalysts Inbound (Upgrade) Seeking Alpha
ABSIAbsci Corporation Stock news Absci Corporation $ABSI Shares Bought by Bank of America Corp DE Defense World
ABSIAbsci Corporation Press release Absci to Participate in Upcoming Investor Conferences GlobeNewswire
ABSIAbsci Corporation Stock news AMD's $1.3 Billion Portfolio Reveals Its Biggest Investments and Where AI Demand Lands Next 24/7 Wall Street
ABSIAbsci Corporation Stock news 4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma Zacks Investment Research
ABSIAbsci Corporation Stock news National CineMedia Posts Downbeat Q2 Results, Joins Borr Drilling, AbCellera Biologics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Benzinga
ABSIAbsci Corporation Stock news Absci Corporation (ABSI) Q2 2026 Earnings Call Transcript Seeking Alpha
ABSIAbsci Corporation Stock news Absci Q2 Earnings Call Highlights MarketBeat
ABSIAbsci Corporation Press release Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results GlobeNewsWire
ABSIAbsci Corporation Stock news The Biggest IPO of the Year Is Targeted in the Next 60 Days. Why One Unexpected Industry Could Rally Before Then (Hint: It’s Not Tech) 247 Wallst
ABSIAbsci Corporation Press release Absci to Report Business Updates and Second Quarter 2026 Financial and Operating Results on August 11, 2026 GlobeNewsWire
ABSIAbsci Corporation Stock news Wall Street Analysts Predict a 28.3% Upside in ABSCI CORP (ABSI): Here's What You Should Know Zacks Investment Research
See more
FAQ

Questions about Absci Corporation

What does Absci Corporation do?
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using an integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
What is ABSI's market cap?
Absci Corporation (ABSI) is a listed stock with a live quote. The latest market cap on this page is $1.6B.
Where is Absci Corporation headquartered?
Absci Corporation is headquartered in Vancouver, WA.
How do I get ABSI news from the API?
Call GET /v1/news?tickers=ABSI. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does ABSI news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ABSI, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the ABSI price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs